Published in Ann Rheum Dis on October 01, 2000
[Definition, classification and diagnosis of fibromyalgia syndrome]. Schmerz (2008) 2.38
A prospective study of the consulting behaviour of older people with knee pain. Br J Gen Pract (2006) 1.16
Association of suboptimal health status and cardiovascular risk factors in urban Chinese workers. J Urban Health (2012) 1.10
Studying the association between musculoskeletal disorders, quality of life and mental health. A primary care pilot study in rural Crete, Greece. BMC Musculoskelet Disord (2009) 1.06
Management of acute neck pain in general practice: a prospective study. Br J Gen Pract (2007) 0.88
Suboptimal health: a new health dimension for translational medicine. Clin Transl Med (2012) 0.85
Management in non-traumatic arm, neck and shoulder complaints: differences between diagnostic groups. Eur Spine J (2008) 0.85
Management decisions in nontraumatic complaints of arm, neck, and shoulder in general practice. Ann Fam Med (2009) 0.79
Musculoskeletal pain in older adults at the end-of-life: a systematic search and critical review of the literature with priorities for future research. BMC Palliat Care (2013) 0.77
Prevalence, diagnostics and management of musculoskeletal disorders in primary health care in Sweden - an investigation of 2000 randomly selected patient records. J Eval Clin Pract (2016) 0.75
Therapeutic exercise for athletes with nonspecific neck pain: a current concepts review. Sports Health (2012) 0.75
Revisiting the behavioral model and access to medical care: does it matter? J Health Soc Behav (1995) 38.24
Measurement of patient outcome in arthritis. Arthritis Rheum (1980) 21.31
Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum (1983) 5.96
Low back pain in eight areas of Britain. J Epidemiol Community Health (1992) 4.61
A cost-of-illness study of back pain in The Netherlands. Pain (1995) 4.02
Scientific approach to the assessment and management of activity-related spinal disorders. A monograph for clinicians. Report of the Quebec Task Force on Spinal Disorders. Spine (Phila Pa 1976) (1987) 3.69
How well can a few questionnaire items indicate anxiety and depression? Acta Psychiatr Scand (1993) 2.48
Most chronic diseases are reported more frequently by individuals with fewer than 12 years of formal education in the age 18-64 United States population. J Chronic Dis (1987) 2.06
Chronic widespread pain in the community: the influence of psychological symptoms and mental disorder on healthcare seeking behavior. J Rheumatol (1999) 1.90
Prevalence of low back pain in the community: implications for service provision in Bradford, UK. J Epidemiol Community Health (1996) 1.62
Self-report questionnaire scores in rheumatoid arthritis compared with traditional physical, radiographic, and laboratory measures. Ann Intern Med (1989) 1.57
The International Classification of Primary Care (ICPC): new applications in research and computer-based patient records in family practice. Fam Pract (1996) 1.52
Use of primary health services in sparsely populated country districts by patients with musculoskeletal symptoms: consultations with a physician. J Epidemiol Community Health (1993) 1.48
Work incapacity from low back pain in the general population. Spine (Phila Pa 1976) (1998) 1.29
Community survey of factors associated with consultation for low back pain. BMJ (1998) 1.26
Musculoskeletal pain and quality of life in patients with noninflammatory joint pain compared to rheumatoid arthritis: a population survey. J Rheumatol (1997) 1.10
A summary of the impact of musculoskeletal conditions in the United States. Arthritis Rheum (1990) 1.02
Health care utilization for low back pain in Belgium. Influence of sociocultural factors and health beliefs. Spine (Phila Pa 1976) (1995) 1.00
[What symptoms and complaints result in sick-listing? ICPC-coding of patients' own opinion in general practice]. Tidsskr Nor Laegeforen (1992) 0.95
Development of criteria for the diagnosis of fibrositis. Am J Med (1986) 0.86
Relationships between social background and medical care in osteoarthritis. J Rheumatol (1993) 0.84
[Validity of health interview surveys]. Tidsskr Nor Laegeforen (1975) 0.80
Why does acute back pain become chronic? BMJ (1997) 0.79
Concern Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med (2000) 29.03
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 6.36
EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis (2009) 5.82
EULAR evidence based recommendations for gout. Part I: Diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis (2006) 4.59
ASAS/EULAR recommendations for the management of ankylosing spondylitis. Ann Rheum Dis (2005) 4.31
Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Trøndelag diabetes study. J Epidemiol Community Health (1992) 3.67
Current tobacco smoking, formal education, and the risk of rheumatoid arthritis. J Rheumatol (1999) 2.93
European League Against Rheumatism recommendations for the management of psoriatic arthritis with pharmacological therapies. Ann Rheum Dis (2011) 2.74
Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum (2000) 2.71
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison. Lancet (2000) 2.63
[New knowledge on alendronate (Fosamax) and fractures]. Tidsskr Nor Laegeforen (1999) 2.56
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Ann Rheum Dis (2008) 2.55
ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis (2008) 2.37
Intra-atrial ECG is not a reliable method for positioning left internal jugular vein catheters. Br J Anaesth (2003) 2.21
Sulfasalazine in the treatment of spondylarthropathy. A randomized, multicenter, double-blind, placebo-controlled study. Arthritis Rheum (1995) 2.16
Consensus statement on the use of rituximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 2.07
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis. Ann Rheum Dis (2011) 2.06
The role of somatosensory evoked potentials in detecting cerebral ischaemia during carotid endarterectomy. Eur J Anaesthesiol (2008) 2.05
Toward a data-driven evaluation of the 2010 American College of Rheumatology/European League Against Rheumatism criteria for rheumatoid arthritis: is it sensible to look at levels of rheumatoid factor? Arthritis Rheum (2011) 2.01
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative. Ann Rheum Dis (2011) 1.97
Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity. J Clin Epidemiol (1998) 1.93
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study. Ann Rheum Dis (2007) 1.87
Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies. Ann Rheum Dis (2008) 1.84
Magnetic resonance imaging findings in 84 patients with early rheumatoid arthritis: bone marrow oedema predicts erosive progression. Ann Rheum Dis (2007) 1.78
Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo controlled trial versus sulfasalazine. Ann Rheum Dis (2001) 1.78
Reduced bone mineral density in male rheumatoid arthritis patients: frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register. Arthritis Rheum (2000) 1.77
Etanercept and sulfasalazine, alone and combined, in patients with active rheumatoid arthritis despite receiving sulfasalazine: a double-blind comparison. Ann Rheum Dis (2006) 1.77
Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Arthritis Rheum (2008) 1.66
Health and re-employment in a two year follow up of long term unemployed. J Epidemiol Community Health (1993) 1.65
Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis. Ann Rheum Dis (2006) 1.64
Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev (2008) 1.61
Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up. Ann Rheum Dis (2008) 1.60
Rapid changes in the prevalence of obesity and known diabetes in an adult Norwegian population. The Nord-Trøndelag Health Surveys: 1984-1986 and 1995-1997. Diabetes Care (1999) 1.59
Disease activity and health status in rheumatoid arthritis: a case-control comparison between Norway and Lithuania. Ann Rheum Dis (2003) 1.58
Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis (2009) 1.56
Lower level of synovial fluid interferon-gamma in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis. Rheumatology (Oxford) (2003) 1.55
EULAR recommendations for calcium pyrophosphate deposition. Part II: management. Ann Rheum Dis (2011) 1.54
Cytokines, autoantibodies and viral antibodies in premorbid and postdiagnostic sera from patients with rheumatoid arthritis: case-control study nested in a cohort of Norwegian blood donors. Ann Rheum Dis (2007) 1.51
A coding polymorphism in NALP1 confers risk for autoimmune Addison's disease and type 1 diabetes. Genes Immun (2008) 1.47
Detecting hypertension: screening versus case finding in Norway. BMJ (1991) 1.41
[Estrogen substitution is better than alendronate (Fosamax)]. Tidsskr Nor Laegeforen (1998) 1.39
[Effect of feedback and self-evaluation on the prescription of addictive drugs]. Tidsskr Nor Laegeforen (1991) 1.39
Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol (1995) 1.37
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis (2009) 1.36
Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology. J Rheumatol (1999) 1.35
Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative. Ann Rheum Dis (2008) 1.32
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases. Genes Immun (2005) 1.32
The potential for research-based information in public health: identifying unrecognised information needs. BMC Public Health (2001) 1.31
Hand cortical bone mass and its associations with radiographic joint damage and fractures in 50-70 year old female patients with rheumatoid arthritis: cross sectional Oslo-Truro-Amsterdam (OSTRA) collaborative study. Ann Rheum Dis (2004) 1.26
Work disability in rheumatoid arthritis is predicted by physical and psychological health status: a 7-year study from the Oslo RA register. Scand J Rheumatol (2006) 1.26
Performance of health status measures with a pen based personal digital assistant. Ann Rheum Dis (2005) 1.25
A comparison of agreement and sensitivity to change between AIMS2 and a short form of AIMS2 (AIMS2-SF) in more than 1,000 rheumatoid arthritis patients. J Rheumatol (2000) 1.24
Health status of patients with ankylosing spondylitis: a comparison with the general population. Ann Rheum Dis (2004) 1.24
Amplification of plasmid and chromosome Chlamydia DNA in synovial fluid of patients with reactive arthritis and undifferentiated seronegative oligoarthropathies. Arthritis Rheum (1995) 1.21
Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study. Ann Rheum Dis (2008) 1.20
Identification of disease activity and health status cut-off points for the symptom state acceptable to patients with rheumatoid arthritis. Ann Rheum Dis (2007) 1.18
Screening for toxoplasmosis in pregnancy: what is the evidence of reducing a health problem? J Med Screen (1996) 1.18
Seven year changes in health status and priorities for improvement of health in patients with rheumatoid arthritis. Ann Rheum Dis (2005) 1.18
Lipids, myocardial infarction and ischaemic stroke in patients with rheumatoid arthritis in the Apolipoprotein-related Mortality RISk (AMORIS) Study. Ann Rheum Dis (2010) 1.17
Activity limitations and participation restrictions in women with hand osteoarthritis: patients' descriptions and associations between dimensions of functioning. Ann Rheum Dis (2005) 1.17
Natural killer (NK) cell activity of peripheral blood, synovial fluid, and synovial tissue lymphocytes from patients with rheumatoid arthritis and juvenile rheumatoid arthritis. Ann Rheum Dis (1982) 1.16
Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2. Rheumatology (Oxford) (1999) 1.16
Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity. Ann Rheum Dis (2007) 1.15
The incidence and severity of rheumatoid arthritis, results from a county register in Oslo, Norway. J Rheumatol (1998) 1.15
Rheumatoid arthritis is milder in the new millennium: health status in patients with rheumatoid arthritis 1994-2004. Ann Rheum Dis (2008) 1.14
Evidence-based recommendations for the management of ankylosing spondylitis: systematic literature search of the 3E Initiative in Rheumatology involving a broad panel of experts and practising rheumatologists. Rheumatology (Oxford) (2008) 1.13
Sustained-release naltrexone for opioid dependence. Cochrane Database Syst Rev (2008) 1.13
The course of rheumatoid arthritis and predictors of psychological, physical and radiographic outcome after 5 years of follow-up. Rheumatology (Oxford) (2000) 1.12
Ultrasonography shows increased cross-sectional area of the median nerve in patients with arthritis and carpal tunnel syndrome. Rheumatology (Oxford) (2005) 1.10
Musculoskeletal pain and quality of life in patients with noninflammatory joint pain compared to rheumatoid arthritis: a population survey. J Rheumatol (1997) 1.10
Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis (1999) 1.09
Serum IgG antibodies to peptidylarginine deiminase 4 predict radiographic progression in patients with rheumatoid arthritis treated with tumour necrosis factor-alpha blocking agents. Ann Rheum Dis (2008) 1.08
Physiotherapy interventions for ankylosing spondylitis. Cochrane Database Syst Rev (2004) 1.08
The limits of leadership: opinion leaders in general practice. J Health Serv Res Policy (1998) 1.04
Test-retest reliability of disease activity core set measures and indices in rheumatoid arthritis. Ann Rheum Dis (2008) 1.04
Self reported non-vertebral fractures in rheumatoid arthritis and population based controls: incidence and relationship with bone mineral density and clinical variables. Ann Rheum Dis (2004) 1.04
Disease activity and severity in patients with rheumatoid arthritis: relations to socioeconomic inequality. Soc Sci Med (1999) 1.04
Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis (2001) 1.04
Perception of improvement in patients with rheumatoid arthritis varies with disease activity levels at baseline. Arthritis Rheum (2009) 1.03
Laser monitoring of chest wall displacement. Eur Respir J (1997) 1.03
Work disability and health-related quality of life in males and females with psoriatic arthritis. Ann Rheum Dis (2008) 1.02
Correlates of patients' global assessment of arthritis impact. A 2-year study of 216 patients with RA. Scand J Rheumatol (1997) 1.01
National health insurance consumption and chronic symptoms following mild neck sprain injuries in car collisions. Scand J Soc Med (1996) 1.00